Rockville biotech Shuttle Pharmaceuticals files for its IPO — for the second time


The company is developing a treatment to make radiation more effective for cancer patients.

Previous Here's a look inside Life Connection of Ohio's new $12M HQ (Photos)
Next St. Jude scientists identify link between interferon treatment and cell death during COVID-19